IPP Bureau
Solara Active Pharma Sciences consolidated Q1FY26 PAT rises to Rs. 10.52 Cr
By IPP Bureau - July 26, 2025
Solara Active Pharma Sciences has reported total income of Rs. 320.13 crores during the period ended June 30, 2025
.jpg "Cipla reports Q1 FY2025-26 consolidated profit up at Rs. 1,297.62 Cr")
Cipla reports Q1 FY2025-26 consolidated profit up at Rs. 1,297.62 Cr
By IPP Bureau - July 26, 2025
Cipla has reported total income of Rs. 7,216.03 crores during the period ended June 30, 2025
RPG Life Sciences Q1 FY2026 PAT slips to Rs. 26.29 Cr
By IPP Bureau - July 26, 2025
RPG Life Sciences has reported total income of Rs. 174.15 crores during the period ended June 30, 2025
Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa
By IPP Bureau - July 26, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
48 projects approved under PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs
By IPP Bureau - July 24, 2025
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
NATCO Pharma API unit in Mekaguda receives EIR from USFDA
By IPP Bureau - July 24, 2025
The company received one observation in the Form-483
Lupin receives USFDA approvals for Liraglutide and Glucagon injectable products
By IPP Bureau - July 24, 2025
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Zydus receives tentative approval from USFDA for Ibrutinib tablets
By IPP Bureau - July 24, 2025
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr
By IPP Bureau - July 24, 2025
Revenue increased 11.4 per cent to Rs. 8,545 crore
Pfizer completes licensing agreement with 3SBio to expand oncology portfolio
By IPP Bureau - July 24, 2025
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
Godavari Biorefineries secures Chinese patent for anti-cancer molecule
By IPP Bureau - July 23, 2025
UFlex secures Indian patent for waterborne heat seal coating for food, consumer goods packaging
By IPP Bureau - July 23, 2025
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Max Lab partners with Stepcare to expand in Bengaluru
By IPP Bureau - July 23, 2025
This partnership aims to address the growing demand for high-quality diagnostics in metropolitan areas
Akums launches high-strength Paracetamol oral suspension 500mg/5ml
By IPP Bureau - July 23, 2025
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Cipla to invest in iCaltech to strengthen respiratory play
By IPP Bureau - July 23, 2025
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
